KDIGO
KDIGO
  • Видео 205
  • Просмотров 441 163
KDIGO 2024 CKD Guidelines Unpacked: Hear it Straight from the Experts
This webcast, moderated by Vivek Jha, MD (India), and featuring presentations by Edgar V. Lerma, MD (United States) and Giorgina Piccoli, MD (Italy), addresses the implications of the 2024 KDIGO CKD Guideline and ways to delay the progression of CKD.
The webcast was originally recorded on July 23, 2024.
Просмотров: 1 725

Видео

IPNA-ISN-KDIGO Webinar - Contemporary Management of SSNS and SRNS: Latest Guidance from IPNA & KDIGO
Просмотров 9682 месяца назад
This webinar is designed to enhance the knowledge and clinical skills of healthcare professionals in managing steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS). Viewers will gain a thorough understanding of the guideline recommendations from the ISN, IPNA, and KDIGO. The session delves into the interpretation and practical application of these guideline...
APOL1 Controversies Conference Plenary Presentation: APOL1 Diagnostics and Therapeutics
Просмотров 2832 месяца назад
This is a recording of the plenary presentation, "APOL1 Diagnostics and Therapeutics," by Dr. Kirk Campbell (United States) from the KDIGO Controversies Conference on APOL1 Kidney Disease. Dr. Akinlolu Ojo (United States) and Dr. Ifeoma Ulasi (Nigeria) co-chaired this conference in Accra, Ghana, in April 2024. The conference brought together key thought leaders and relevant stakeholders, includ...
APOL1 Controversies Conference Plenary: Patient & Caregiver Panel Discussion
Просмотров 882 месяца назад
This is a recording of the Patient & Caregiver Panel Discussion from the KDIGO Controversies Conference on APOL1 Kidney Disease. The discussion took place during the conference plenary presentations. Dr. Akinlolu Ojo (United States) and Dr. Ifeoma Ulasi (Nigeria) co-chaired this conference in Accra, Ghana, in April 2024. The conference brought together key thought leaders and relevant stakehold...
APOL1 Controversies Conference Plenary: Ethics of Genetic Testing
Просмотров 992 месяца назад
This is a recording of the plenary presentation, "Ethics of Genetic Testing," by Dr. Rulan Parekh (Canada) from the KDIGO Controversies Conference on APOL1 Kidney Disease. Dr. Akinlolu Ojo (United States) and Dr. Ifeoma Ulasi (Nigeria) co-chaired this conference in Accra, Ghana, in April 2024. The conference brought together key thought leaders and relevant stakeholders, including patients, car...
APOL1 Controversies Conference Plenary: Epidemiology of APOL1 Kidney Disease
Просмотров 1992 месяца назад
This is a recording of the plenary presentation, "Epidemiology of APOL1 Kidney Disease," by Dr. Sarala Naicker (South Africa) from the KDIGO Controversies Conference on APOL1 Kidney Disease. Dr. Akinlolu Ojo (United States) and Dr. Ifeoma Ulasi (Nigeria) co-chaired this conference in Accra, Ghana, in April 2024. The conference brought together key thought leaders and relevant stakeholders, incl...
APOL1 Controversies Conference Plenary: APOL1 Pathophysiology
Просмотров 2872 месяца назад
This is a recording of the plenary presentation "APOL1 Pathophysiology" by Dr. David Friedman (United States) from the KDIGO Controversies Conference on APOL1 Kidney Disease. Dr. Akinlolu Ojo (United States) and Dr. Ifeoma Ulasi (Nigeria) co-chaired this conference in Accra, Ghana, in April 2024. The conference brought together key thought leaders and relevant stakeholders, including patients, ...
Personalizing Our Approach: A Focus on Managing the Non-diabetic Patient in CKD
Просмотров 9203 месяца назад
This is the fifth webinar in a five-part series on the holistic approach to evaluating and managing chronic kidney disease (CKD) based on the KDIGO 2024 CKD Guideline. In this webinar, KDIGO CKD Guideline Work Group Members Rasheeda Hall, MD (United States) and William Herrington, MD (United Kingdom) guide attendees through an interactive case study to show the step-wise approach to managing pa...
KDIGO 2024 Guideline on Lupus Nephritis (LN): A Roundtable Discussion
Просмотров 3,4 тыс.3 месяца назад
This is a recording of the session "KDIGO 2024 Guideline on Lupus Nephritis (LN): A Roundtable Discussion" from the 2024 ERA Congress in Stockholm, Sweden. The session was co-chaired by KDIGO LN Guideline Co-Chair Brad Rovin, MD (United States) and LN Guideline Work Group Member Vladimir Tesar, MD (Czechia), with presentations by LN Guideline Work Group Members Juan Manuel Mejía Vilet, MD (Mexi...
KDIGO Scientific Symposium on the Impact of Viral Infection and the Role of Vaccines in Kidney Care
Просмотров 6423 месяца назад
This is a recording of the KDIGO scientific symposium, "The Impact of Viral Infections in Patients with Renal Diseases and the Role of Vaccination in Kidney Care," which was held at the 61st ERA Congress in Stockholm, Sweden, in May 2024. The symposium was chaired by Steven Chadban, MD (Australia), with speakers Uyen Huynh-Do, MD (China), Michel Jadoul, MD (Belgium), and Deepali Kumar, MD (Cana...
KDIGO Heart Failure & Kidney Disease Conference Plenary: Patient Panel
Просмотров 3113 месяца назад
This is a recording of the patient panel plenary presentation from the KDIGO 2024 Controversies Conference on Kidney Disease and Heart Failure: Recent Advances and Current Challenges. The conference was held in Vancouver, Canada, in March 2024. Dr. Nisha Bansal (University of Washington, United States) and Dr. Carolyn Lam (National Heart Centre Singapore and Duke-National University of Singapor...
KDIGO Heart Failure & CKD Conference Plenary: Prediction of Heart Failure in Patients with CKD
Просмотров 4533 месяца назад
This is a recording of "Prediction of Heart Failure in Patients with CKD," a plenary presentation by Dr. Josef Coresh (Optimal Aging Institute and NYU Grossman School of Medicine, United States) from the KDIGO 2024 Controversies Conference on Kidney Disease and Heart Failure: Recent Advances and Current Challenges. The conference was held in Vancouver, Canada, in March 2024. Dr. Nisha Bansal (U...
KDIGO Heart Failure & Kidney Disease Conference Plenary: Interdisciplinary Care Models
Просмотров 2603 месяца назад
This is a recording of "Interdisciplinary Care Models: Implementation Strategies to Address Global Unmet Needs," a plenary presentation by Dr. Elke Eaton (University Hospitals Cleveland, United States), Dr. Debasish Banerjee (St George's University Hospitals NHS Foundation Trust, United Kingdom), and Dr. Lisa Anderson (St George's Hospital London, United Kingdom) from the KDIGO 2024 Controversi...
KDIGO Heart Failure & Kidney Disease Conference Plenary: A New Era of GDMT
Просмотров 1,3 тыс.3 месяца назад
This is a recording of "A New Era of GDMT: Are We Witnessing a Convergence of GDMT for Heart Failure and CKD?," a plenary presentation by Dr. Brendon Neuen (Royal North Shore Hospital and The George Institute for Global Health, Australia) from the KDIGO 2024 Controversies Conference on Kidney Disease and Heart Failure: Recent Advances and Current Challenges. The conference was held in Vancouver...
KDIGO Heart Failure & Kidney Disease Conference Plenary: New AHA CKM Staging
Просмотров 5833 месяца назад
This is a recording of "New AHA Cardiovascular-Kidney-Metabolic (CKM) Staging Solves All Our Staging Problems and Should Be Applied Universally: A Cardiology and Nephrology Perspective," a plenary session presentation by Dr. Robert Mentz (Duke University, United States) and Dr. Adeera Levin (University of British Columbia St Paul's Hospital, Canada) from the KDIGO 2024 Controversies Conference ...
KDIGO 2024 Guideline for Chronic Kidney Disease: Key Messages for Primary Care Physicians
Просмотров 1,3 тыс.4 месяца назад
KDIGO 2024 Guideline for Chronic Kidney Disease: Key Messages for Primary Care Physicians
KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines
Просмотров 2,1 тыс.4 месяца назад
KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines
61st ERA Congress Highlights on Complement-Mediated Kidney Disease with Marina Vivarelli
Просмотров 5324 месяца назад
61st ERA Congress Highlights on Complement-Mediated Kidney Disease with Marina Vivarelli
61st ERA Congress Highlights on IgA Nephropathy with Jonathan Barratt
Просмотров 9644 месяца назад
61st ERA Congress Highlights on IgA Nephropathy with Jonathan Barratt
A Contemporary Approach to Treatment of Anemia for Dialysis Patients: A KDIGO Perspective
Просмотров 1,2 тыс.4 месяца назад
A Contemporary Approach to Treatment of Anemia for Dialysis Patients: A KDIGO Perspective
Expert Roundtable Discussion on Dialysis-Related Amyloidosis (DRA)
Просмотров 4314 месяца назад
Expert Roundtable Discussion on Dialysis-Related Amyloidosis (DRA)
Dialysis-Related Amyloidosis (DRA): We Still Have a Long Way to Go
Просмотров 3094 месяца назад
Dialysis-Related Amyloidosis (DRA): We Still Have a Long Way to Go
Dialysis-Related Amyloidosis: A Perspective from the US
Просмотров 3724 месяца назад
Dialysis-Related Amyloidosis: A Perspective from the US
Pathophysiology of Dialysis-Related Amyloidosis: B2-Microglobulin-Related Amyloid Fibril Formation
Просмотров 4454 месяца назад
Pathophysiology of Dialysis-Related Amyloidosis: B2-Microglobulin-Related Amyloid Fibril Formation
KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment
Просмотров 4,5 тыс.4 месяца назад
KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment
Part 2: An Expert Approach to Cardiorenal Protection in CKD
Просмотров 8244 месяца назад
Part 2: An Expert Approach to Cardiorenal Protection in CKD
Part 1: An Expert Approach to Cardiorenal Protection in CKD
Просмотров 1,3 тыс.4 месяца назад
Part 1: An Expert Approach to Cardiorenal Protection in CKD
Optimising RAASi Management in Cardiorenal Patients
Просмотров 7024 месяца назад
Optimising RAASi Management in Cardiorenal Patients
Personalizing Our Approach: A Focus on Targeting Diabetes with Concomitant CKD
Просмотров 8604 месяца назад
Personalizing Our Approach: A Focus on Targeting Diabetes with Concomitant CKD
Personalizing Our Approach: A Focus on the Diagnosis and Prognosis of CKD
Просмотров 9064 месяца назад
Personalizing Our Approach: A Focus on the Diagnosis and Prognosis of CKD

Комментарии

  • @KathleenMoore-w6q
    @KathleenMoore-w6q 23 часа назад

    Durgan Common

  • @sarahmansoor6173
    @sarahmansoor6173 3 дня назад

    I was diagnosed with C3GN at age 9 in 2014. Since then I've had renal biopsy procedures, been on steriods, immunosuppressive drugs, ACE inhibitors and so much more. I had nephrotic range proteinuria for 8 years and 2 years ago my proteinuria fell below the nephrotic range and entered sub-nephrotic range proteinuria. When I was given cyclosporin, I had a huge reaction to it and became severely hypertensive, had PRES syndrome and ended up in a coma. I'm hopeful as the research of this rare condition gets further, they can find treatments and cures for these complicated diseases.

  • @BettyWalker-n3r
    @BettyWalker-n3r 3 дня назад

    Hauck Manors

  • @JamesDavis-g2m
    @JamesDavis-g2m 4 дня назад

    Deshawn Ridge

  • @sarahmansoor6173
    @sarahmansoor6173 6 дней назад

    I was diagnosed with C3GN at age 9 in 2014. At that time they diagnosed it as MPGN type 1, but after reclassification, my doctor confirmed it as C3GN. Have had so many treatments, tests, biopsies, taken part in research trial, but Im glad to see that research is started to get us further in treatments for these rare diseases.

  • @MorleyLambert-c6q
    @MorleyLambert-c6q 8 дней назад

    Camilla Mountain

  • @JohnCarpenter-k7f
    @JohnCarpenter-k7f 13 дней назад

    Hoppe Locks

  • @JohnsonAlva-q2n
    @JohnsonAlva-q2n 13 дней назад

    Clarabelle Forges

  • @ft_ph
    @ft_ph 18 дней назад

    Such a helpful and easy to understand discussion. Thank you so much Dr. Lerma, proud to see a Filipino role model. Hoping to learn more and become a better physician as I embark on my nephro fellowship this yr! 😊

  • @MariaLee-o9k
    @MariaLee-o9k 18 дней назад

    Hoeger Ville

  • @BernardSmith-d7y
    @BernardSmith-d7y 21 день назад

    Clovis Fort

  • @MackintoshIsaac-u7r
    @MackintoshIsaac-u7r 26 дней назад

    Jacobi Vista

  • @clettomaravanyika4651
    @clettomaravanyika4651 Месяц назад

    Informative

  • @husamsalim7143
    @husamsalim7143 Месяц назад

    Thank you

  • @husamsalim7143
    @husamsalim7143 Месяц назад

    Thank you all

  • @husamsalim7143
    @husamsalim7143 Месяц назад

  • @husamsalim7143
    @husamsalim7143 Месяц назад

  • @husamsalim7143
    @husamsalim7143 Месяц назад

    🙏

  • @SamRice-j2l
    @SamRice-j2l Месяц назад

    Anderson Carol Moore Maria White Donald

  • @SamRice-j2l
    @SamRice-j2l Месяц назад

    Taylor Sandra Hernandez Cynthia Walker Kenneth

  • @SamRice-j2l
    @SamRice-j2l Месяц назад

    Taylor Elizabeth Rodriguez Christopher Johnson Jose

  • @JohnVessely
    @JohnVessely 2 месяца назад

    Very Informative. We Can also use Mutrakrichantak churan of Planet Ayurveda, its a magic herb I must say.

  • @marettalisa2316
    @marettalisa2316 2 месяца назад

    I got IGA from covid infection!

  • @grandmajane2593
    @grandmajane2593 2 месяца назад

    Nothing new here to report, folks.

  • @ShimmyMD
    @ShimmyMD 2 месяца назад

    What an excellent video /summary. Great job 👏🏼

  • @ShimmyMD
    @ShimmyMD 2 месяца назад

    Dr Tangri - one comment (constructive criticism if I may) I looked at the guidelines and they make a note that nuclear imaging is not as reliable as something like iohexol. Maybe I’m missing something?

  • @ShimmyMD
    @ShimmyMD 2 месяца назад

    Dr Tangri is an excellent teacher. I’m glad you were part of this panel.

  • @ShimmyMD
    @ShimmyMD 2 месяца назад

    Amazing presentation. I really like the panel style. Keeps it interactive.

  • @DoctorsTalking-hj2qv
    @DoctorsTalking-hj2qv 2 месяца назад

    how to pronounce this word?

  • @gerrraw
    @gerrraw 2 месяца назад

    Thanks

  • @RafaelLMello01
    @RafaelLMello01 3 месяца назад

    crie um projeto react com java script, contendo os seguintes itens: crie um componente react que renderize um botão com o texto: “Clique aqui” crie um componente react que renderize uma lista de números. a Lista deve ser atualizada quando o usuário clicar no botão na questão anterior crie um componente react que renderize um formulário de login. O formulário deve ter os campos e-mail e senha. crie um roteamento que inclua pelo menos duas páginas diferentes sendo uma delas: um texto informativo com alguns parágrafos sobre a importância dos softwares nos dias atuais e a outra um texto informativo sobre negócios. integre o framework bootstrap com a aplicação react. todos os elementos devem ter o seu estilo modificado pelo framework implemente uma rota de navegação autenticada em react. ou seja, crie um fluxo em que o usuário só pode acessar determinada rota se estiver autenticado. as credenciais do usuário obtidas pelo formulário de login podem ser verificadas diretamente com strings pré-definidas no código como email = “admin” e senha igual a “1234” para autenticar o usuário. as interfaces devem seguir heurísticas de ux design e ui design para ficarem melhores

  • @claudio5995
    @claudio5995 3 месяца назад

    Hello. Why CKD G1 is >90 and have no an upper limit? When there is hyperfiltration?

  • @Koronajewell
    @Koronajewell 3 месяца назад

    I'm a dialysis patient in the US. I take fish oils every morning before dialysis instead of using heparin as a blood thinner. The one day I forgot to take my fish oil, the dialysis machine clotted up. Fish oil does work for me.

  • @Dr_Sri_Harsha_Guthikonda
    @Dr_Sri_Harsha_Guthikonda 3 месяца назад

    Certainly! Based on the video transcript, here are the chapters for the video: **Chapter 1: Introduction to IGA Nephropathy and FSGS Webinar** [00:00:05][^1^][1] - Greetings and welcome - Overview of the webinar series - Introduction of speakers **Chapter 2: Diagnosing IGA Nephropathy** [00:01:17][^2^][2] - Pathology basis for diagnosis - Characteristics of IGA Nephropathy - Differential diagnosis and distinguishing factors **Chapter 3: Pathophysiology and Clinical Aspects of IGA Nephropathy** [00:13:22][^3^][3] - Historical perspective of IGA Nephropathy - Clinical trials and targeting pathways - Importance of blood pressure control and lifestyle modifications **Chapter 4: Biopsy Predictors and Stratification** [00:07:24][^4^][4] - The role of renal biopsy in diagnosis and prognosis - International consensus on classification - The Oxford approach to classification **Chapter 5: Clinical Implications of Biopsy Findings** [00:42:42][^5^][5] - The significance of crescents in IGA Nephropathy - The importance of clinical context in treatment decisions **Chapter 6: Lifestyle Modifications and Patient Management** [00:32:23][^6^][6] - Supportive therapy approaches - The impact of diet, obesity, and smoking on IGA Nephropathy - Recommendations for physical activity **Chapter 7: Conclusion and Q&A Session** [00:47:13][^7^][7] - Summary of key points from the webinar - Audience questions and expert responses - Closing remarks and future webinars These chapters provide a structured overview of the video's content, making it easier to navigate through the different topics discussed. If you need more detailed information or specific time stamps for each chapter, feel free to ask!

  • @bondardmytro2783
    @bondardmytro2783 3 месяца назад

    What is MRST classification?

  • @darkeio
    @darkeio 3 месяца назад

    thank you so much for your lecture

  • @kevinwellwrought2024
    @kevinwellwrought2024 3 месяца назад

    My protein 24 hour is over 1000. As long as I take cortisol it stays the same but whenever I stop it startd going over 1000. This proves that cortisols are just like painkillers and do not treat IGA and second IGA has no treatment and medical sciences are all defeated by it

  • @a.m.hherez3460
    @a.m.hherez3460 3 месяца назад

    Whats GDMT

    • @vietleuc913
      @vietleuc913 3 месяца назад

      Guideline-Directed Medical Therapy

  • @kleptocracyrulez763
    @kleptocracyrulez763 3 месяца назад

    Wonderful discussion...

  • @dipeesingh9242
    @dipeesingh9242 3 месяца назад

    Does that mean weight lifting causes blood pressure to be raised to a level that it damages kidney irreversibly everytime? Very counter intuitive!!!

  • @drvishwaprakashtiwari1217
    @drvishwaprakashtiwari1217 4 месяца назад

    Any suggestion regarding duration of maintance

  • @hamadaadl5637
    @hamadaadl5637 4 месяца назад

    Thanks

  • @hamadaadl5637
    @hamadaadl5637 5 месяцев назад

    Thank you

  • @badrulmunir8042
    @badrulmunir8042 5 месяцев назад

    Thank you for sharing

  • @conjeevaramkesavan5467
    @conjeevaramkesavan5467 6 месяцев назад

    Excellent thoughts Several Major issues Lack of concern for humanity and no forethought Total inertia even in application of measures Big pharma driving business for pharmacotherapy using human Guinea pigs paying medical professionals Ruthless greed making cost of newer medicines absolutely unaffordable No one bothered about prevention and no effort made on implementing life style interventions aggressively in real world Great talk appreciate his insight forethought with total compassion and caring He needs to be rewarded

  • @jonathanbolanos3825
    @jonathanbolanos3825 6 месяцев назад

    I'm confused. He said referral to nephrology when eGFR <30, yet the guideline says transition to nephrology care when eGFR<60.

  • @abifantaw
    @abifantaw 6 месяцев назад

    am internal medicine resident in ethiopia these lectures help me alot thanks

  • @ShilpaSharma-tf4of
    @ShilpaSharma-tf4of 6 месяцев назад

    Very Informative. We Can also use Mutrakrichantak churan of Planet Ayurveda, its a magic herb I must say.

  • @ahmedahm1
    @ahmedahm1 9 месяцев назад

    34:50 The caveat is that ACEi/ARBs are effective in persons with albuminuria +/- DM (benefit in patients without albuminuria is less consistent)

  • @GloriaAynera
    @GloriaAynera 9 месяцев назад

    Thank you so much. I need to know more from this new guidelines. God bless to all kdigo group.